SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 70 filers reported holding SYNERON MEDICAL LTD in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $834,000 | -7.2% | 76,200 | -10.6% | 0.00% | 0.0% |
| Q1 2017 | $899,000 | +19.7% | 85,200 | -4.7% | 0.00% | 0.0% |
| Q4 2016 | $751,000 | -4.3% | 89,400 | -18.4% | 0.00% | 0.0% |
| Q3 2016 | $785,000 | +8.7% | 109,625 | +16.8% | 0.00% | 0.0% |
| Q2 2016 | $722,000 | +23.4% | 93,825 | +17.2% | 0.00% | 0.0% |
| Q1 2016 | $585,000 | +8.1% | 80,025 | +14.0% | 0.00% | 0.0% |
| Q4 2015 | $541,000 | -12.2% | 70,225 | -18.5% | 0.00% | 0.0% |
| Q3 2015 | $616,000 | -33.5% | 86,200 | -1.3% | 0.00% | 0.0% |
| Q2 2015 | $927,000 | -2.8% | 87,300 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $954,000 | 0.0% | 87,300 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $954,000 | +174.9% | 87,300 | +152.3% | 0.00% | – |
| Q3 2014 | $347,000 | -2.8% | 34,600 | 0.0% | 0.00% | – |
| Q2 2014 | $357,000 | -9.6% | 34,600 | 0.0% | 0.00% | -100.0% |
| Q1 2014 | $395,000 | -5.7% | 34,600 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $419,000 | +40.6% | 34,600 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $298,000 | +39.9% | 34,600 | +41.2% | 0.00% | – |
| Q2 2013 | $213,000 | – | 24,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acrospire Investment Management LLC | 2,738 | $30,000 | 90.91% |
| BRANDES INVESTMENT PARTNERS, LP | 2,901,971 | $31,921,000 | 0.65% |
| Lapides Asset Management, LLC | 186,200 | $2,044,000 | 0.42% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 51,703 | $569,000 | 0.04% |